Kazia Therapeutics Limited. Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019
Kazia Therapeutics Limited. (KZIA) had Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 of 0.957 AUD/shares as of 2023-06-30, per its 20-F filed 2023-10-26.
Discontinued › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 · last filed 2023-10-26
- 2023-06-30: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 0.96 AUD/shares.
- 2022-06-30: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 0.88 AUD/shares.
- 2021-06-30: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 0.62 AUD/shares.
| Period end | Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 |
|---|---|
| 2023-06-30 | 0.96 AUD/shares 20-F · filed 2023-10-26 |
| 2022-06-30 | 0.88 AUD/shares 20-F · filed 2023-10-26 |
| 2021-06-30 | 0.62 AUD/shares 20-F · filed 2022-10-17 |